Dexmedetomidine: A review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation

Drugs

Volumn 71, Issue 11, 2011, Pages 1481-1501

  Hoy, Sheridan M ^a   Keating, Gillian M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Drug Evaluations; Dexmedetomidine, general; Intensive care units; Sedation

Indexed keywords

ATROPINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450; DEXMEDETOMIDINE; FENTANYL; INOTROPIC AGENT; LORAZEPAM; MIDAZOLAM; MORPHINE; NORADRENALIN; OPIATE; PARACETAMOL; PLACEBO; PROPOFOL;

ANALGESIA; ANEMIA; ANTIHYPERTENSIVE THERAPY; ARTIFICIAL VENTILATION; ATELECTASIS; BLEEDING; BRADYCARDIA; BRADYPNEA; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG FEVER; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG PROTEIN BINDING; DRUG TOLERABILITY; DRUG TRANSFORMATION; DRUG UTILIZATION; DRUG WITHDRAWAL; EXTUBATION; GENERAL ANESTHESIA; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART RATE; HORMONE RELEASE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; HYPOXIA; INFUSION RATE; INTENSIVE CARE; INTUBATION; KIDNEY DISEASE; LENGTH OF STAY; LIVER DISEASE; LOADING DRUG DOSE; LOCUS CERULEUS; NAUSEA; NONHUMAN; OXYGEN SATURATION; PAIN; PAIN ASSESSMENT; PLASMA PROTEIN BINDING; POSTANESTHESIA CARE; POSTOPERATIVE NAUSEA AND VOMITING; PRURITUS; RADIOACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; REVIEW; RIGOR; SEDATION; SIDE EFFECT; SINUS ARREST; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; URINE RETENTION; VAGUS TONE; VOMITING; XEROSTOMIA;

ANESTHESIA; CONSCIOUS SEDATION; DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; MALE; RESPIRATION, ARTIFICIAL;

EID: 79961139017     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11207190-000000000-00000     Document Type: Review

References (66)

1. Practice guidelines for sedation and analgesia by nonanesthesiologists. Anesthesiology 2002 Apr; 96 (4): 1004-17.
2. Brown TB, Lovato LM, Parker D. Procedural sedation in the acute care setting. Am Fam Physician 2005 Jan 1; 71 (1): 85-90. (Pubitemid 40096057)
3. Wunsch H, Kahn JM, Kramer AA, et al. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009Dec 1; 37 (12): 3031-9.
4. Gan TG. Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet 2006; 45 (9): 855-69.
5. Wunsch H, Kress JP. A new era for sedation in ICU patients. JAMA 2009 Feb; 301 (5): 542-4.
6. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000 Feb; 59 (2): 263-8; discussion 269-70. (Pubitemid 30168513)
7. Hospira Inc. Precedex (dexmedetomidine hydrochloride) injection: prescribing information [online]. Available from URL: http://www.accessdata.fda. gov/drugsatfda-docs/la bel/2010/021038s017lbl.pdf [Accessed 2011 Jul 14].
8. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a metaanalysis. Intensive Care Med 2010 Jun; 36 (6): 926-39.
9. Murthy TVSP, Singh R. Alpha 2 adrenoceptor agonist-dexmedetomidine role in anaesthesia and intensive care: a clinical review. J Anaesthesiol Clin Pharmacol 2009; 25 (3): 267-72.
10. Haselman MA. Dexmedetomidine: a useful adjunct to consider in some high-risk situations. AANA J 2008 Oct; 76 (5): 335-9.
11. Panzer O, Moitra V, Sladen RN. Pharmacology of sedativeanalgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009 Jul; 25 (3): 451-69.
12. Arcangeli A, D'Alò C, et al. Dexmedetomidine use in general anaesthesia. Curr Drug Targets 2009 Aug; 10 (8): 687-95.
13. Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an a2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992 Jun; 76 (6): 948-52.
14. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000 Aug; 93 (2): 382-94. (Pubitemid 30620311)
15. Hsu Y-W, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics. Part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004 Nov; 101 (5): 1066-76. (Pubitemid 39430785)
16. Cortinez LI, Hsu YW, Sum-Ping ST, et al. Dexmedetomidine pharmacodynamics. Part II: crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004 Nov; 101 (5): 1077-83. (Pubitemid 39430786)
17. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999 Sep; 83 (3): 372-80. (Pubitemid 29412688)
18. Dutta S, Karol MD, Cohen T, et al. Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci 2001 Feb; 90 (2): 172-81. (Pubitemid 32158045)
19. Bloor BC, Ward DS, Belleville JP, et al. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992 Dec; 77 (6): 1134-42. (Pubitemid 23001124)
20. Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidineinduced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg 2002 Oct; 95 (4): 1052-9.
21. Drummond JC, Dao AV, Roth DM, et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008; 108 (2): 225-32. (Pubitemid 351156732)
22. Iirola T, Vilo S, Aantaa R, et al. Dexmedetomidine inhibits gastric emptying and oro-caecal transit in healthy volunteers. Br J Anaesth 2011 Apr; 106 (4): 522-7.
23. Sulemanji DS, Donmez A, Aldemir D, et al. Dexmedetomidine during coronary artery bypass grafting surgery: is it neuroprotective? A preliminary study. Acta Anaesthesiol Scand 2007 Sep; 51 (8): 1093-8. (Pubitemid 47246914)
24. Shiokawa Y, Inamori M, Tsukamoto I, et al. Effects of continuous infusion of dexmedetomidine on hemodynamics and blood oxygenation. Anesth Resusc 2009; 45 (3): 65-7.
25. Apan A, Doganci N, Ergan A, et al. Bispectral index-guided intraoperative sedation with dexmedetomidine and midazolam infusion in outpatient cataract surgery. Minerva Anestesiol 2009 May; 75 (5): 239-44.
26. Elvan EG, Oc B, Uzun S, et al. Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy. Eur J Anaesthesiol 2008 May; 25 (5): 357-64. (Pubitemid 351465526)
27. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999 Dec; 54 (12): 1136-42.
28. Arain SR, Ruehlow RM, Uhrich TD, et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 2004 Jan; 98 (1): 153-8. (Pubitemid 38029869)
29. TekinM, Kati I, Tomak Y, et al. Effect of dexmedetomidine IV on the duration of spinal anesthesia with prilocaine: a double-blind, prospective study in adult surgical patients. Curr Ther Res Clin Exp 2007; 68 (5): 313-24. (Pubitemid 350266607)
30. Coskuner I, Tekin M, Kati I, et al. Effects of dexmedetomidine on the duration of anaesthesia and wakefulness in bupivacaine epidural block. Eur J Anaesthesiol 2007 Jun; 24 (6): 535-40. (Pubitemid 46787799)
31. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001 Nov; 87 (5): 684-90. (Pubitemid 33069556)
32. Venn RM, Bryant A, Hall GM, et al. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001 May; 86 (5): 650-6. (Pubitemid 32409406)
33. Abdalla MIM, Al MF, Bener A. Dexmedetomidine during local anesthesia. J Anesth 2006; 20 (1): 54-6. (Pubitemid 43125784)
34. Inan SA, Ozkose Z. Dexmedetomidine's effect on QT interval and QT dispersion undergoing total intravenous anaesthesia [abstract]. 14th World Congress of Anaesthesiologists; 2008 Mar 2-7; Cape Town.
35. Ozkose Z, Aciksoz S. The effect of dexmedetomidine on QT interval [abstract]. 14th World Congress of Anaesthesiologists; 2008 Mar 2-7; Cape Town.
36. Cooper L, Candiotti K, Gallagher C, et al. A randomized, controlled trial on dexmedetomidine for providing adequate sedation and hemodynamic control for awake, diagnostic transesophageal echocardiography. J Cardiothorac Vasc Anesth 2011 Apr; 25 (2): 233-7.
37. Al-MustafaMM, Badran IZ, Abu-Ali HM, et al. Intravenous dexmedetomidine prolongs bupivacaine spinal analgesia. Middle East J Anesthesiol 2009 Jun; 20 (2): 225-31.
38. Kaya FN, Yavascaoglu B, Turker G, et al. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth 2010 Jan; 57 (1): 39-45.
39. Abdulatif M, Hamed HM, el-Borolossy K, et al. A comparative study of the use of dexmedetomidine and propofol as sedatives for mechanically ventilated patients in ICU. Egypt J Anaesth 2004; 20 (4): 437-42. (Pubitemid 39585935)
40. Rutkowska K, Knapik P, Misiolek H. The effect of dexmedetomidine sedation on brachial plexus block in patients with end-stage renal disease. Eur J Anaesthesiol 2009 Oct; 26 (10): 851-5.
41. Martin E, Ramsay G, Mantz J, et al. The role of the a2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003 Jan-2003 28; 18 (1): 29-41. (Pubitemid 44526587)
42. Bergese SD, Candiotti KA, Bokesch PM, et al. A phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther 2010 Nov-Dec; 17 (6): 586-95.
43. Candiotti KA, Bergese SD, Bokesch PM, et al. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg 2010 Jan; 110 (1): 47-56.
44. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth 2002 May; 88 (5): 669-75. (Pubitemid 34498595)
45. De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001 Nov; 93 (5): 1205-9. (Pubitemid 33021018)
46. US Food and Drug Administration. Center for Drug Evaluation and Research. Medical review(s). Part 1 [online]. Available from URL: http://www.accessdata. fda.gov/drugsatfda-docs/nda/99/21-038-Precedex-medr-P1.pdf [Accessed 2011 Jul 15].
47. US Food and Drug Administration. Center for Drug Evaluation and Research. Medical review(s). Part 2 [online]. Available from URL: http://www.accessdata. fda.gov/drugsatfda-docs/nda/99/21-038-Precedex-medr-P2.pdf [Accessed 2011 Jul 15].
48. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990 Aug; 10 (4): 244-51. (Pubitemid 20319177)
49. Maldonado JR, Wysong A, van der Starre PJ, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009 May-Jun 30; 50 (3): 206-17.
50. Liu LL, Gropper MA. Postoperative analgesia and sedation in the adult intensive care unit: a guide to drug selection. Drugs 2003; 63 (8): 755-67. (Pubitemid 36428445)
51. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002 Jan; 30 (1): 119-41. (Pubitemid 34112188)
52. Arnold HM, Hollands JM, Skrupky LP, et al. Optimizing sustained use of sedation inmechanically ventilated patients: focus on safety. Curr Drug Saf 2010 Jan; 5 (1): 6-12.
53. Shehabi Y, Botha JA, Boyle MS, et al. Sedation and delirium in the intensive care unit: an Australian and New Zealand perspective. Anaesth Intensive Care 2008 Jul; 36 (4): 570-8. (Pubitemid 352030246)
54. Morandi A, Watson PL, Trabucchi M, et al. Advances in sedation for critically ill patients. Minerva Anestesiol 2009 Jun; 75 (6): 385-91.
55. Jaakola M-L. Dexmedetomidine as a preanaesthetic agent: phase I-III studies with a novel, specific a2-adrenoceptor agonist. Acta Anaesthesiol Scand 1998; 42 (2): 276-7. (Pubitemid 28067902)
56. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009 Feb; 301 (5): 489-99.
57. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007 Dec; 298 (22): 2644-53. (Pubitemid 350254956)
58. Orion Corporation Orion Pharma. Dexmedetomidine versus midazolam for continuous sedation in the intensive care unit (ICU) [MIDEX] [ClinicalTrials.gov identifier NCT00481312]. US National Institutes of Health, Clinical-Trials.gov [online]. Available from URL: http://clinical trials.gov [Accessed 2011 Jun 22].
59. Orion Corporation Orion Pharma. Dexmedetomidine versus propofol for continuous sedation in the intensive care unit (ICU) [Prodex] [ClinicalTrials.gov identifier NCT00479661]. USNational Institutes of Health, Clinical-Trials.gov [online]. Available from URL: http://clinical trials.gov [Accessed 2011 Jun 22].
60. Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg 2008 Jun; 106 (6): 1741-8.
61. Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth 2006; 18 (1): 24-8. (Pubitemid 43330764)
62. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: ameta-analysis. AmJMed 2003 Jun 15; 114 (9): 742-52. (Pubitemid 36776356)
63. Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 1997 Feb; 86 (2): 331-45. (Pubitemid 27093378)
64. But AK, Ozgul U, Erdil F, et al. The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand 2006 Nov; 50 (10): 1207-12. (Pubitemid 44624299)
65. Dasta JF, Kane-Gill SL, Pencina M, et al. A costminimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010 Feb; 38 (2): 497-503.
66. Shehabi Y, Riker RR, Bokesch PM, et al. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010 Dec; 38 (12): 2311-8.